---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000834210.md"
description: "$Ultragenyx Pharma(RARE.US) | Guggenheim 𝗺𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝘀 𝗕𝘂𝘆 on 𝗨𝗹𝘁𝗿𝗮𝗴𝗲𝗻𝘆𝘅 𝗣𝗵𝗮𝗿𝗺𝗮, cuts PT to $𝟯𝟱 from $𝟰𝟯Analyst sees a binary ASPIRE outcome, with overwhelming success driving $55–$65 and failure sending RARE to the low teens."
datetime: "2026-08-04T11:57:36.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000834210.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000834210.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000834210.md)
author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)"
generator: "portal-rs"
---

# $Ultragenyx Pharma(RARE.US) | Guggenheim 𝗺𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝘀…


### Related Stocks

- [RARE.US](https://longbridge.com/en/quote/RARE.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**